📊 Score Breakdown
Offering Ability
100
Cash Runway
0
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
52%
🔁 Convertible Conversion
60%
• Major convertible overhang: 1493% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration
50%
• Score rose 40 points recently (worsening)
• Score in HIGH risk zone (61/100)
💰 Capital Raise
38%
• Active shelf registration ($5000M, 4590% of market cap)
• Active ATM program with $600M remaining capacity
💹 Market Data
Market Cap$108.94M
Shares Outstanding17.40M
Float10.93M
Cash$35.30M
Debt$210.11M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 20.4% shares (2025Q4 vs prior)
64 institutional holders · 134.93M shares
#1
Alyeska Investment Group, L.P.
25.61M shares
#2
Hunting Hill Global Capital, LLC
13.31M shares
#3
Yorkville Advisors Global, LP
9.30M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest30.83M
Days to Cover5.8
% of Float282.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
EFFECT
EFFECT
Apr 23, 2026
EFFECT
EFFECT
Apr 23, 2026
S-3/A
SHELF
Apr 17, 2026
S-3/A
SHELF
Apr 17, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NAKA
📊 NAKA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NAKA Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.